Major depression is traditionally treated with psychotherapy and antidepressant medication. These treatments are considered first-line treatment options. Specifically, in the case of antidepressants, these medications are thought to increase the levels of under-performing neurotransmitters in the brain. While these changes have a positive effect for many, unfortunately, antidepressant medications do not work for all patients and even when medications are effective, there may still be some serious side effects to consider.
Antidepressant medications are chemicals that are typically taken by mouth. These chemicals circulate in the bloodstream throughout the body. In some patients, they may result in unwanted side effects, such as weight gain, sexual problems, upset stomach, sleepiness, and dry mouth. In addition, there is often a delay to the onset of action, as the medication circulates through the body before it effectively reaches its target in the brain.
TMS is an expanding field in medicine.
Studies show that Chronic fatigue syndrome, Chronic fibromyalgia patients, and OCD patients will benefit from treatment with TMS therapy.
More than 4 million patients do not receive adequate benefit from antidepressants and/or cannot tolerate the associated side effects. For these patients, alternative treatments are available. Transcranial Magnetic Stimulation has been proven to work in people that do not receive complete benefit from antidepressants, and/or cannot tolerate the side effects caused by medication.
Extensive research into Transcranial Magnetic Stimulation (TMS) has created safer and effective alternative treatments for Depression, Chronic fatigue syndrome and OCD.
The process of focusing electromagnetic pulses at specific regions of the brain results in TMS activating and raising the levels of neurotransmitters in areas shown to be under-performing in affected patients.
TMS is a very effective treatment for Depression, Chronic Fatigue Syndrome, and OCD and provides a viable therapeutic option for those who have not benefited from prior antidepressant medication or other management protocols.